COGT Cogent Biosciences, Inc.

Formerly Unum Therapeutics Inc., the company is a biotechnology company focused on developing precision therapies for genetically defined diseases.

$4.73
As of 05/20/2022     IEX book   CBOE book

---

Security Information

---

Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  03/29/2018
Outstanding shares:  45,819,266
Average volume:  334,263
Market cap:   $208,935,853
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BLR6XK8

---

Valuation   (See tab for details)

---

PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%